The groundbreaking rise of Viagra has consistently remained a example of pharmaceutical success, however its legacy within the broader market now triggers questions about future yields . Copycat versions are diminishing exclusivity , causing concerns that investing in companies heavily reliant to Viagra's previous position could be a dangerous stra